Human papillomavirus infection in non-cervical sites in India
- PMID: 40752644
- DOI: 10.1016/j.ijmmb.2025.100948
Human papillomavirus infection in non-cervical sites in India
Abstract
Background: Human papillomaviruses are sexually transmitted viruses that have cutaneous and mucosal tropism. While usually cleared by the immune system, persistent infection can lead to cancer. HPV-related tumours account for 5 % of all cancers and over 30 % of cancers of infectious aetiology. One out of every 13 cancers in India are from HPV-related sites. The role of HPV in cervical cancer is well established, but has also been implicated in non-cervical malignancies including penile, anal, vulvar, vaginal, and head and neck cancers. The prevalence and distribution of HPV-related non-cervical cancers, however, varies globally and remains underreported in countries like India with a paucity of large-scale, population-based studies.
Objectives: A literature search of the PubMed database was conducted using relevant MeSH terms and keywords. The findings aimed to summarize the existing literature on HPV-associated non-cervical cancers in India, the implicated HPV genotypes across anatomical sites, and identify possible research gaps in surveillance, screening, and possible prevention strategies.
Content: In this article, we have reviewed Indian studies against the backdrop of the global scenario, reporting the presence of HPV in non-cervical cancers and high-risk populations. Findings revealed considerable HPV prevalence in non-cervical malignancies in India: 42.5 % in penile cancers, 52.2 % in anal cancers, 22.8-44.8 % in oropharyngeal cancers, and 7.5-34.1 % in laryngeal cancers. HPV-16 was the predominant genotype identified across most tumours. Additionally, high-risk groups particularly HIV-positive MSMs, exhibited elevated HPV DNA positivity from anal, penile and scrotal sites. Overall, in India, there was a lack of robust, population-based data and standardized diagnostic protocols. The absence of routine HPV testing and screening and the limited implementation of HPV vaccination further compound this public health challenge. Enhanced epidemiological surveillance, screening and vaccination are needed to address the rising burden of HPV-related non-cervical cancers.
Keywords: Human papillomavirus; Oropharyngeal squamous cell carcinoma; Squamous cell carcinoma.
Copyright © 2025 Indian Association of Medical Microbiologists. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Interventions targeted at women to encourage the uptake of cervical screening.Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3. Cochrane Database Syst Rev. 2021. PMID: 34694000 Free PMC article.
-
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.Cochrane Database Syst Rev. 2018 May 9;5(5):CD009069. doi: 10.1002/14651858.CD009069.pub3. Cochrane Database Syst Rev. 2018. PMID: 29740819 Free PMC article.
-
A scoping review of human papillomavirus related data system in China.BMC Infect Dis. 2025 Jul 1;25(1):873. doi: 10.1186/s12879-025-11106-y. BMC Infect Dis. 2025. PMID: 40597707 Free PMC article.
-
The Utility of an Human Papillomavirus Genotype Assay for Cancer Screening in Self-Collected Urine and Vaginal Samples from Japanese Women.Gynecol Obstet Invest. 2025;90(2):143-152. doi: 10.1159/000541641. Epub 2024 Oct 7. Gynecol Obstet Invest. 2025. PMID: 39374596 Free PMC article.
-
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.Cochrane Database Syst Rev. 2008 Jul 16;(3):CD001230. doi: 10.1002/14651858.CD001230.pub2. Cochrane Database Syst Rev. 2008. PMID: 18646068
LinkOut - more resources
Full Text Sources